4100 Group led an extension to the healthcare AI technology provider's latest round and was joined by several existing corporate investors.

The fitness and sleep tracker provider, an alumnus of Harvard Innovation Lab, was valued at $1.2bn in a round that took its total funding past $200m.

Turning Point Brands has supplied $15m for cannabinoid health product developer Dosist through a co-development and distribution pact.

Citi Ventures and Bloomberg Beta were among the participants in the enterprise information software developer's series A round.

Bloomberg Beta and HearstLab-backed IT authorisation tool developer StrongDM has added $17m to the $5m it had previously raised.

Spun out of University of Louisville, Koligo Therapeutics has already launched its first cell therapy product and aims to commercialise a treatment for covid-19.

University of Utah's newly launched software-focused accelerator is backed by an early-stage fund of undisclosed size.

The insurance and finance management app developer raised the money in a CNO Financial-led round backed by Samsung Ventures, Securian Ventures, Guardian Life and Nippon Life.

The restaurant ordering technology provider boosted its overall funding to more than $150m, closing a round led by SoftBank Vision Fund.

The fitness and sleep tracker provider was valued at $1.2bn in a round that involved SoftBank Vision Fund coming on board as a new investor.